Lexicon Pharmaceuticals, Inc. (LXRX): Insiders Aren’t Crazy About It

Page 1 of 2

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) investors should pay attention to an increase in activity from the world’s largest hedge funds recently.

In the 21st century investor’s toolkit, there are a multitude of metrics investors can use to monitor stocks. A duo of the best are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best fund managers can trounce the broader indices by a significant margin (see just how much).

Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)Equally as integral, bullish insider trading sentiment is another way to break down the investments you’re interested in. Just as you’d expect, there are a variety of incentives for an insider to get rid of shares of his or her company, but only one, very clear reason why they would buy. Many academic studies have demonstrated the market-beating potential of this strategy if investors understand what to do (learn more here).

Consequently, it’s important to take a gander at the recent action regarding Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX).

Hedge fund activity in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)

At the end of the first quarter, a total of 9 of the hedge funds we track were long in this stock, a change of 29% from the previous quarter. With hedgies’ sentiment swirling, there exists a select group of notable hedge fund managers who were increasing their stakes meaningfully.

When looking at the hedgies we track, Royce & Associates, managed by Chuck Royce, holds the largest position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX). Royce & Associates has a $9.6 million position in the stock, comprising less than 0.1%% of its 13F portfolio. Coming in second is Joseph Edelman of Perceptive Advisors, with a $7 million position; 0.8% of its 13F portfolio is allocated to the company. Remaining peers that hold long positions include Steven Cohen’s SAC Capital Advisors, Mario Gabelli’s GAMCO Investors and Ken Griffin’s Citadel Investment Group.

Now, key money managers have been driving this bullishness. Citadel Investment Group, managed by Ken Griffin, created the largest position in Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX). Citadel Investment Group had 0.3 million invested in the company at the end of the quarter. Matthew Tewksbury’s Stevens Capital Management also initiated a $0 million position during the quarter. The only other fund with a brand new LXRX position is Israel Englander’s Millennium Management.

What have insiders been doing with Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)?

Insider purchases made by high-level executives is at its handiest when the company in focus has seen transactions within the past half-year. Over the latest half-year time period, Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) has seen zero unique insiders buying, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX). These stocks are Nektar Therapeutics (NASDAQ:NKTR), PDL BioPharma Inc. (NASDAQ:PDLI), Sarepta Therapeutics Inc (NASDAQ:SRPT), VIVUS, Inc. (NASDAQ:VVUS), and Santarus, Inc. (NASDAQ:SNTS). This group of stocks are the members of the biotechnology industry and their market caps resemble LXRX’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!